One in Two: A Manchester Cancer Research Podcast
Season 2 - Lung Cancer: From basic biology to transformative therapies
Lung Cancer in never smokers with Dr Fabio Gomes: The ALK positive mutation in Non-Small Cell Lung Cancer (NSCLC)
With one in two of us receiving a cancer diagnosis at some point during our lives, it has never been more important to improve the outcomes for people affected by cancer.
In this episode, we speak to Dr Fabio Gomes, a Consultant Medical Oncologist at The Christie NHS Foundation Trust, about lung cancer in never smokers, focusing on:
- The commonality of lung cancer in never smokers
- Why never smokers are susceptible to lung cancer, and why you only need lungs to get lung cancer
- ALK positive mutations in non-small cell lung cancer
- His research project looking at The UK ALK project
- The ALK Education programme and educating healthcare professionals through data and case studies
There is a subgroup of patients who have actually never smoked or smoked very little and they are still presenting with lung cancer, which is really hard for them. And that leads often to delays in diagnosis and I think it's about focussing on that awareness that actually you only need lungs to get lung cancer, so if something isn't adding up, even if you've never smoked, you should be getting this investigated.
Dr Fabio Gomes
Dr Fabio Gomes
Dr Fabio Gomes is a Consultant Medical Oncologist who specialises in the care of patients with lung cancer. He also has a special interest in the care of senior adults with cancer and is the Clinical Director of the multidisciplinary senior adult oncology service launched at The Christie in 2022.
Fabio also works with the digital services where he directs the clinical outcomes unit. This unit focuses on the use of clinical data generated as part of the daily practice across the hospital to identify the outcomes of groups of patients and promote improvements.
Dr Gomes is an elected board member of the International Society of Geriatric Oncology (SIOG). He is also a Clinical Research Training Fellow alum at The University of Manchester.
The series has been produced in partnership with the Cancer Beacon at The University of Manchester.
Previous episodes from season one covering early detection research and other episodes from season two covering lung cancer research are available now on Spotify, Apple Podcasts, and The University of Manchester or MCRC YouTube Channel.
Cancer biomarkers with Professor Caroline Dive: How liquid biopsies could pave the way for lung cancer detection and treatment
The basic biology of lung cancer with Dr Colin Lindsay: Exploring oncogenic drivers such as the KRAS mutation
Season One now available – One in Two: A Manchester Cancer Research Podcast
One in Two: A Manchester Cancer Research Podcast